We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

62 hedge funds and large institutions have $6.47M invested in Cardiff Oncology in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% less ownership

Funds ownership: 0.26% → 0.25% (-0.01%)

5% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 20

9% less funds holding

Funds holding: 68 → 62 (-6)

25% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 8

46% less capital invested

Capital invested by funds: $12.1M → $6.47M (-$5.61M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $76K

Holders
62
Holders Change
-6
Holders Change %
-8.82%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
19
Reduced
20
Closed
8
Calls
–
Puts
$76K
Net Calls
-$76K
Net Calls Change
+$106K

Top Buyers

1
BlackRock
BlackRock
New York
+$3.14M
2
VKH
Virtu KCG Holdings
New York
+$337K
3
TSS
Two Sigma Securities
New York
+$165K
4
EP
Elkhorn Partners
Nebraska
+$120K
5
TRCT
Tower Research Capital (TRC)
New York
+$80.8K

Top Sellers

1
Millennium Management
Millennium Management
New York
-$317K
2
Morgan Stanley
Morgan Stanley
New York
-$169K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$156K
4
HighTower Advisors
HighTower Advisors
Illinois
-$141K
5
Citigroup
Citigroup
New York
-$53.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
51
Royal Bank of Canada
Ontario, Canada
$3K +$951 +7 +21%
IP
52
Intellectus Partners
California
$2K – – –
TWA
53
TCI Wealth Advisors
Arizona
$2K +$543 +4 +16%
AIP
54
Ameritas Investment Partners
Nebraska
$2K +$3.53K +26 New
LWM
55
LBA Wealth Management
Florida
$2K +$3.8K +28 New
MAM
56
Meeder Asset Management
Ohio
$1K -$9.64K -71 -83%
Simplex Trading
57
Simplex Trading
Illinois
$1K -$2.44K -18 -47%
Carson Wealth (CWM LLC)
58
Carson Wealth (CWM LLC)
Nebraska
$1K – – –
Manulife (Manufacturers Life Insurance)
59
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1K – – –
WP
60
WealthPLAN Partners
Nebraska
$440 +$815 +6 New
BNP Paribas Financial Markets
61
BNP Paribas Financial Markets
France
$145 -$2.58K -19 -90%
Citigroup
62
Citigroup
New York
– -$53.2K -392 -99%
D.E. Shaw & Co
63
D.E. Shaw & Co
New York
– -$38K -250 Closed
CS
64
Credit Suisse
Switzerland
– -$37K -243 Closed
Jane Street
65
Jane Street
New York
– -$35K -230 Closed
AIM
66
Acrospire Investment Management
Illinois
– -$9K -58 Closed
HCM
67
Highlander Capital Management
New Jersey
– -$4K -28 Closed
PNC Financial Services Group
68
PNC Financial Services Group
Pennsylvania
– -$2K -14 Closed
CG
69
Cutler Group
California
– -$1K -8 Closed
1 2
3

CRDF Hedge Fund Activity: Q1 2017 in Review

62 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Cardiff Oncology (CRDF) for Q1 2017, worth a combined $6.47M — down 46% from $12.1M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of CRDF and 6 opened new positions — a net loss of 2 holders — while 20 trimmed existing stakes and 19 added.

The largest buyer was BlackRock, adding an estimated $3.14M. The largest seller was Millennium Management, cutting an estimated $317K.

  • 62 institutional investors held Cardiff Oncology (CRDF) as of Q1 2017, down from 68 in Q4 2016.
  • Funds reported $6.47M of Cardiff Oncology stock for Q1 2017, down 46% quarter-over-quarter.
  • 6 funds opened new Cardiff Oncology positions in Q1 2017 and 8 closed out, a net change of -2 holders.
  • The largest Cardiff Oncology buyer in Q1 2017 was BlackRock, an estimated $3.14M added.
  • The largest Cardiff Oncology seller in Q1 2017 was Millennium Management, an estimated $317K sold.

Based on aggregated 13F filings for Q1 2017.